Bill Text: HI HB1659 | 2020 | Regular Session | Amended
Bill Title: Relating To Health.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Enrolled - Dead) 2020-07-10 - Transmitted to Governor. [HB1659 Detail]
Download: Hawaii-2020-HB1659-Amended.html
|
HOUSE OF REPRESENTATIVES |
H.B. NO. |
1659 |
|
THIRTIETH LEGISLATURE, 2020 |
H.D. 3 |
|
|
STATE OF HAWAII |
S.D. 1 |
|
|
|
|
|
|
|
||
|
|
||
A BILL FOR AN ACT
RELATING TO HEALTH.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
Section 1. Chapter
328, Hawaii Revised Statutes, is amended by adding a new section to part I to
be appropriately designated and to read as follows:
"§328‑ Customized patient medication package. (a)
A pharmacy may provide a customized patient medication package to any
person; provided that:
(1) The pharmacy
has obtained the consent of the patient, patient's caregiver, patient's
guardian, or prescribing practitioner; provided that the consent may be
communicated in writing, orally, or by electronic transmission; provided
further that the format of the consent shall be identified on the prescription
record required to be maintained under section 328-17.7;
(2) The consent is
accompanied by the patient's current prescription; and
(3) The customized
patient medication package meets the requirements of section 328-16.
(b) As used in this section, "customized patient medication package" means a package that is prepared by a pharmacist for a specific patient and contains one or more prescribed solid oral dosage forms."
SECTION 2. Section 329-14, Hawaii Revised Statutes, is amended to read as follows:
"(b) Any of the following opiates, including their
isomers, esters, ethers, salts, and salts of isomers, esters, and ethers,
unless specifically excepted, whenever the existence of these isomers, esters,
ethers, and salts is possible within the specific chemical designation:
(1) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
(2) Acetylmethadol;
(3) Allylprodine;
(4) Alphacetylmethadol (except levo-alphacetylmethadol, levomethadyl acetate, or LAAM);
(5) Alphameprodine;
(6) Alphamethadol;
(7) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine);
(8) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
(9) Benzethidine;
(10) Betacetylmethadol;
(11) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide);
(12) Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide);
(13) Betameprodine;
(14) Betamethadol;
(15) Betaprodine;
(16) Clonitazene;
(17) Dextromoramide;
(18) Diampromide;
(19) Diethylthiambutene;
(20) Difenoxin;
(21) Dimenoxadol;
(22) Dimepheptanol;
(23) Dimethylthiambutene;
(24) Dioxaphetyl butyrate;
(25) Dipipanone;
(26) Ethylmethylthiambutene;
(27) Etonitazene;
(28) Etoxeridine;
(29) Furethidine;
(30) Hydroxypethidine;
(31) Ketobemidone;
(32) Levomoramide;
(33) Levophenacylmorphan;
(34) 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide);
(35) 3-methylthiofentanyl (N-[3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
(36) Morpheridine;
(37) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
(38) Noracymethadol;
(39) Norlevorphanol;
(40) Normethadone;
(41) Norpipanone;
(42) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl] propanamide;
(43) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine;
(44) Phenadoxone;
(45) Phenampromide;
(46) Phenomorphan;
(47) Phenoperidine;
(48) Piritramide;
(49) Proheptazine;
(50) Properidine;
(51) Propiram;
(52) Racemoramide;
(53) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide);
(54) Tilidine;
(55) Trimeperidine;
(56) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl), its optical isomers, salts, and salts of isomers;
(57) N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl), its optical isomers, salts, and salts of isomers;
(58) N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide,
(acetyl fentanyl), its optical, positional, and geometric isomers, salts, and
salts of isomers;
(59) AH-7921 (3,4-dichloro-N-[(1-dimethylamino)
cyclohexylmethyl]benzamide), its isomers, esters, ethers, salts, and salts of isomers,
esters, and ethers;
(60) N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: Butyryl fentanyl);
(61) N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: beta-hydroxythiofentanyl);
(62) N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide,
its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other
names: Furanyl fentanyl); [and]
(63) 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide,
its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers
(Other names: U-47700)[.];
(64) 4-fluoroisobutyryl
fentanyl or para-fluoroisobutyryl fenranyl [N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide];
(65) Acryl fentanyl or
acryloylfentanyl [N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide]; and
(66) Ocfentanil [N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiprtidin-4-yl)acetamide]."
SECTION 3. Statutory material to be repealed is bracketed and stricken. New statutory material is underscored.
SECTION 4. This Act shall take effect upon its approval.
Report Title:
Prescription Drugs; Pharmacy; Customized Patient Medication Packages; Schedule I Controlled Substances
Description:
Authorizes
a pharmacy to provide a customized patient medication package to any person upon
consent, with a valid prescription, and in compliance with labeling and dispensing
requirements. Adds certain substances to
the list of Hawaii's Schedule I controlled substances. (SD1)
The summary description
of legislation appearing on this page is for informational purposes only and is
not legislation or evidence of legislative intent.
